Clinical Oncology
Volume 21, Issue 4 , Pages 315-319 , May 2009

Radiotherapy in Larynx Squamous Cell Carcinoma is not Associated with an Increased Diagnosis of Second Primary Tumours

  • R.D. Farhadieh

      Affiliations

    • St Vincent's Hospital, Melbourne, Australia
    • Prince of Wales Hospital, University of New South Wales, Sydney, Australia
    • Corresponding Author InformationAuthor for correspondence: R. D. Farhadieh, c/o Sister Janette Williams CNS, Department of Radio-Oncology, Prince of Wales Hospital, High St, Randwick 2031, Sydney, Australia. Tel: +61-2-93822595; Fax: +61-2-9382-2550.
  • ,
  • C.G.G. Rees

      Affiliations

    • UNSW, Randwick, NSW, Sydney, Australia
  • ,
  • J.L. Yang

      Affiliations

    • Oncology Research Centre, Prince of Wales Hospital, University of New South Wales, Sydney, Australia
  • ,
  • A. Salardini

      Affiliations

    • University of New South Wales, Sydney, Australia
    • Yale University, New Haven, Connecticut, USA
  • ,
  • P. Russell

      Affiliations

    • Prince of Wales Oncology Centre, University of New South Wales, Sydney, Australia
  • ,
  • R. Smee

      Affiliations

    • Prince of Wales Hospital, University of New South Wales, Sydney, Australia

Received 25 June 2008 ,Revised 7 January 2009 ,Accepted 24 January 2009.

References 

  1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. Cancer J Clin. 2002;52:23–47
  2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72–81
  3. Porceddu SV, Campbell B, Rischin D, et al. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2004;60:365–373
  4. Temam S, Koka V, Mamelle G, et al. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma. Head Neck. 2005;27:653–658
  5. Leemans CR, Tiwari R, Nauta JJ, van der Wall I, Snow G. Recurrence at the primary site in the head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73:187–190
  6. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–1952
  7. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative current radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–1944
  8. Warren S, Gates O. Multiple primary malignant tumours: a survey of the literature and a statistical study. Am J Cancer. 1932;15:1348–1414
  9. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer. 1953;6:963–968
  10. Hall J, Angele S. Radiation DNA damage and cancer. Mol Med Today. 1999;5:157–164
  11. Begg CB, Zhang ZF, Sun M, Herr HW, Schantz SP. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the surveillance, epidemiology, and end results (SEER) program. Am J Epidemiol. 1995;142:653–665
  12. Gao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:427–435
  13. Hashibe M, Ritz B, Le AD, Li G, Sankaranarayanan R, Zhang Z. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett. 2005;220:185–195
  14. Mihara H, Sato T, Yoshino K. Radiation-induced cancers of the head and neck region. Acta Otolaryngol Suppl. 1998;553:60–64
  15. Rusthoven K, Chen C, Raben D, Kavanagh B. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Int J Radiat Oncol Biol Phys. 2008;71(1):192–198
  16. Larson JT, Adams GL, Fattah H. Survival statistics for multiple primaries in head and neck cancer. Otolarnygol Head Neck Surg. 1990;103:14–23
  17. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 1989;17:449–456
  18. Lawson W, Som M. Second primary cancer after irradiation of laryngeal cancer. Ann Otol. 1975;84:771–775
  19. Allison P. Factors associated with smoking and alcohol consumption following treatment for head and neck cancer. Laryngoscope. 2001;37:513–520
  20. Hemminki K, Boffetta P. Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci Publ. 2004;289–297
  21. Mothersill C, Seymour C. Radiation induced bystander effects in unirradiated cells: a review and implications in cancer. Nat Rev Cancer. 2004;4:158–164
  22. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff R. A genetic expansion of Slaughter's concept of field cancerisation: evidence and clinical implications. Cancer Res. 2003;63:1727–1730
  23. Aupérin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999;341:476–484
  24. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. J Am Med Assoc. 1998;280:1485–1489
  25. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343–1353

PII: S0936-6555(09)00038-7

doi: 10.1016/j.clon.2009.01.008

Clinical Oncology
Volume 21, Issue 4 , Pages 315-319 , May 2009